{
  "image_filename": "figure_p1_mrg_det_0_007.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/figure_p1_mrg_det_0_007.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "mrg_det_0_007",
  "claim_id": "claim_007",
  "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
  "supports_claim": false,
  "explanation": "Header of a Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (MMWR) Recommendations and Reports, Vol. 71, No. 1, dated August 26, 2022, showing only the report title and logo. does not support the claim because the image contains only the report header and no data or statements regarding recombinant HA antigens, BEVS, or antibody responses. Note: The image is clear but only shows the title page header with no relevant experimental or clinical data.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Header of a Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (MMWR) Recommendations and Reports, Vol. 71, No. 1, dated August 26, 2022, showing only the report title and logo.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the image contains only the report header and no data or statements regarding recombinant HA antigens, BEVS, or antibody responses.",
    "confidence_notes": "The image is clear but only shows the title page header with no relevant experimental or clinical data."
  }
}